OWKIN was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology and Gilles Wainrib, PhD, a pioneer in the field of Artificial Intelligence in biology.
OWKIN is an AI startup that uses machine learning to augment medical and biology research. The proprietary platform, OWKIN Socrates, uses machine learning technology to integrate biomedical images, genomics and clinical data to discover biomarkers and mechanisms associated with diseases and treatment outcomes.
OWKIN’s $11 million Series A funding round demonstrates the market’s appetite for a digital technology-driven approach to clinical development and medical research.
OWKIN develops scientific collaborations with top-tier medical institutions and partners with leading pharmaceutical companies. OWKIN has developed a state-of-the-art federated learning technology in healthcare to overcome the data sharing problem, building collective intelligence from distributed data at scale while preserving data privacy and security.